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The disc diffusion method, minimum inhibitory concentration (MIC), minimum bactericidal 
concentration (MBC) and gradient-plate techniques were implemented to evaluate the antibacterial 
activity of honey and propolis against Staphylococcus aureus and Escherichia coli. The growth of S. 
aureus was inhibited by application of propolis and honey at concentrations of 2.74 to 5.48 mg ml-1 and 
375.0 at mg ml-1, respectively at both MIC and MBC. The greater inhibition zones (13.0 ± 0.09 to 15.0 ± 
0.11 mm) were observed from propolis at concentrations of 2.74 to 5.48 mg ml-1 in the disc diffusion 
method which was closely correlated with the MIC, MBC and gradient-plate technique results. The 
combined results obtained from the disc diffusion test, MIC, MBC and gradient-plate techniques 
suggested that propolis at concentrations of 2.74 to 3.5 and 3.5 mg ml-1 was effective to inhibit S. 
aureus and E. coli, respectively. On the contrary, honey was effective to inhibit S. aureus at the 
concentration of 375.0 mg ml-1 but failed to inhibit E. coli growth at same concentration. The combined 
results from all methods indicated that both propolis and honey had antibacterial activity against S. 
aureus. Present findings also suggested that S. aureus is more susceptible to the effect of the propolis 
than its Gram-negative counterpart E. coli. 
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INTRODUCTION 
 
Honey and propolis both are very popular because of 
their beneficial effect on human health (Dobrowolski et 
al., 1991) and have been used as folk medicine since 
long (Ghisalberti, 1979; Bankova, 2005; Molan, 1992). 
Both substances are bee product (Zumla and Lulat, 
1989) and contains phenolic substances includes 
cinnamic acid derivatives, some flavonoids (Martos et al., 
1997; Marcucci et al., 2001) which have been verified as 
antibacterial applicant (Miorin et al., 2003). Honey 
contains antioxidants and flavonoids that may function as 
antibacterial agents. Propolis, a flavonoid-rich product of 
honey comb, exhibits antibacterial and anti-inflammatory 
properties  (Bosio  et  al.,  2000)  which  is  very  powerful  
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natural antibiotic (Miorin et al., 2003) and very useful in 
fighting upper respiratory infections, such as common 
cold and influenza viruses (Focht et al., 1993). Propolis 
contains a variety of potent polyphenols which may 
enhance the antistaph activity of some pharmaceutical 
antibiotics including streptomycin (Qiao and Chen, 1991). 
Honey inhibits the growth of dangerous bacteria such as 
Escherichia coli, Staphylococcus aureus, Salmonella, 
Shigella, and Vibrio cholera (Zumla and Lulat, 1989) and 
is superior to several well-known antibiotics. Honey 
inhibits the growth of pathogenic organisms isolated in 
urine samples of patients with urinary tract infections 
(Somal et al., 1994).  
E. coli are a model organism for bacteria (Peter et al., 
1998) and extremely sensitive to antibiotics such as 
streptomycin or gentamycin but rapidly changing and 
acquiring drug resistance (Chapman et al., 2002) due to 
overuse  of  antibiotics  in humans (Johnson et al., 2006).  
  
 
 
 
Management of E. coli infections has been increasingly 
complicated by the emergence of resistance to most first-
line antimicrobial agents including fluoroquinolone 
(Karlowsky et al., 2001). Thus, they have been relied on 
for the treatment of E. coli infections as emerging resis-
tance has progressively eclipsed the utility of alternative 
antimicrobial agents (Gupta et al., 2001). However, the 
prevalence of fluoroquinolone-resistant E. coli has 
reached alarming levels in many parts of the world, 
jeopardizing their usefulness (Raz et al., 2002). The use 
of fluoroquinolones in food animals has been implicated 
in the development of fluoroquinolone resistance in 
zoonotic gram-negative bacilli such as Campylobacter 
and Salmonella species, with the subsequent occurrence 
of drug-resistant infections in humans (Smith et al., 1999; 
Chiu et al., 2002). E. coli that are resistant to quinolones 
and fluoroquinolones contaminate many retail meat 
products, particularly poultry, corresponding with the use 
of fluoroquinolones in food animals, particularly chickens 
and turkeys (Johnson et al., 2003; Johnson et al., 2005). 
However, whether such drug-resistant organisms pose a 
threat to human health is unknown.  
In particular, the similarity between fluoroquinolone-
resistant E. coli from retail chicken products and isolates 
from humans, whether infected or merely colonized, is 
undefined. Food-borne diseases are of major concern 
worldwide and S. aureus is a leading cause of gastro-
enteritis resulting from the consumption of contaminated 
food (Yves et al., 2003). Studies show that 
staphylococcal infections in colonized persons are often 
due to the staphylococcal strain responsible for 
colonization (Calia et al., 1969; Yu et al., 1986) thus, the 
infections have an endogenous origin. Antibacterial and 
antifungal activities of propolis, comparing the suscepti-
bility of microorganisms to different concentrations were 
demonstrated (Fernandes et al., 1995). Agar diffusion 
method was also studied for antibacterial activity of 
beewax and propolis suggested that propolis had 
inhibitory activities against bacterial pathogens (Azevedo 
et al., 1963). Fungistatic and fungicidal effects of propolis, 
especially the susceptibility of yeast to propolis were also 
investigated (Lilenbaum and Barbosa, 1994).  
The chemical composition and antibacterial activity of 
propolis from bees have been reported by Velikova et al. 
(2000a, b) and Marcucci et al. (2001). However there are 
few studies on the honey and proplois under sporadic 
methods against S. aureus and E. coli. Natural antibiotics 
such as propolis and honey may be effective to prevent 
S. aureus and E. coli contamination. Therefore, the goal 
of this study was to investigate the effect of propolis and 
honey with different concentrations on the antibacterial 
activity, since there are limited data in the literature 
concerning combined approach of disc diffusion test, 
MIC, MBC and gradient plate technique. Thus gram-
positive and gram-negative bacteria behavior was 
analyzed   in  increasing  concentrations  of  propolis  and  
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honey in order to determine the minimal inhibitory 
concentration for microbial growth. 
 
 
MATERIALS AND METHODS 
 
A series of experiments were carried out in the laboratory of 
Biotechnology and Engineering Technology, Centennial College, 
HP campus, Toronto, Canada. Different methods were used to 
evaluate the effectiveness of honey and propolis against S. aureus 
and E. coli. Honey and propolis was purchased from Natural 
Medicine Shop, Danforth, Toronto, Canada. Honey was provided by 
Burkes Honey LTD, OMEMEE, ON, Canada. This liquid honey has 
been ranked No. 1 in Canada since 1909. The brand name of the 
propolis is Organika - Canadian Bee Propolis. It is alcohol free and 
100% natural and high potency. Tryptic Soy Agar (TSA) was used 
for the isolation and culture of S. aureus and E. coli.  
Mueller-Hilton broth (MHB brand) was a test medium for 
antimicrobial suscep-tibility testing. Tyrptic Soy Broth (TSB) was 
prepared at the rate of 40 gl-1 of water, dissolved and boiled until 
clear solution appeared, then bottled and autoclaved. TSA was 
poured into sterile petri dish about 15 - 20 ml aseptically then 
allowed about 10 to15 min to settle. For execution of the studies, S. 
aureus and E. coli subculture was done in 5 ml TSB and TSA plate 
and incubated at 35°C for 24 h. The subculture was done prior to 
each trial. Gram-staining and biochemical test was done to confirm 
the supplied microorganisms of S. aureus and E. coli. Honey and 
propolis was used at rates of 750.0 and 10.96 mg ml-1 and both 
honey and propolis samples against S. aureus and E. coli as 
determined by the method of NCCLS (2000).  
 
 
Disc diffusion method 
 
Disc diffusion test was used as an alternative measure of 
susceptibility and a counterpart method of MIC and MBC (NCCLS, 
1996). Aseptically TSA plates were swabbed by S. aureus and E. 
coli. TSA plate was prepared by dipping sterile swabs into 
inoculums for antibiotic disc diffusion. Sterile paper discs (3.5 mm) 
were dipped in different dilution of honey and propolis and placed 
on swab plates for S. aureus and E. coli in specific dilutions and 
placed in agar plate. In each dilution of propolis and honey was 
replicated thrice under factorial completely randomized design. All 
agar plates were incubated at 35°C for 48 h. Observed agar plates 
and measured inhibition’s zone from each paper disc in mm. If the 
test organism grows on the disc it may safely be assumed that the 
test organism is resistant to that honey or propolis.  
 
 
Minimum inhibitory concentration and minimum bactericidal 
concentration 
 
Minimum inhibitory concentration is employed to determine effective 
concentration of honey and propolis against S. aureus and E. coli. 
MHB was employed for the determination of MIC in serial dilution 
tests tube preparation (NCCLS, 2000). Double strength MHB was 
prepared at the rate of 42 g l-1 (NCCLS, 2000). MHB tubes prepared 
with diluted antibiotic and inoculated with organism at the rate of 0.1 
ml per tube. Then all MHB tubes were placed in an incubator at 
35°C for 24 h (120 rpm). Data was recorded to compare with the 
media control MHB tubes. No turbidity clear tube is negative (-) 
while turbid cloudy solution indicated growth (+). Where no growth 
was visible in MIC, the same concentration of MHB tubes included 
honey and propolis tubes was tested at TSA plates for further 
verification  under  MBC.  A  detailed  dilution  schedule of  MIC and  
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Figure 1. Zone of inhibition by application of propolis against E.coli and S. aureus by disc diffusion 
method. Error bar denotes LSD at 0.05. 
 
 
 
growth visibility and non-growth tubes were recorded then further 
proceed with MBC test (NCCLS, 2000).  
 
 
Gradient plate technique 
 
Gradient plate technique was used to validate the MIC and MBC 
test result against S. aureus and E. coli. In this technique propolis 
and honey were used in a TSA plate. The concentration of propolis 
and honey was varied infinitely between zero and a given 
maximum. To perform this test required quantity of propolis and 
honey was mixed with half of total quantity of TSA media then 
poured into a sterile Petri dish and allowed set in the form of a 
wedge. Remain half of the TSA was then poured onto the wedge 
and allowed to set with the Petri dish flat on the table. The plates 
were incubated overnight to allow diffusion of the propolis and 
honey and to dry the surface. The test organism S. aureus and E. 
coli were inoculated in a direction running from the highest to the 
lowest concentration, and placed in the incubator at 35°C for 24 h. 
Observed the inoculated plates and recorded observation. The 
length of growth and the total length of the agar surface streaked 
were measured. Then total length of possible growth is denoted by 
x cm and total length of actual growth y cm, the inhibitory 
concentration as determined by this method is: (c x y)/x mg ml-1, 
where c is the final concentration in mg ml-1 of the propolis and 
honey (Hugo and Denyer, 2004).  
RESULTS  
 
The highest inhibition zone (15.0 ± 0.11 mm) was 
recorded from propolis at the concentration of 5.48 mg 
ml-1 followed by 2.74 mg ml-1 (Figure 1) while honey 
showed slightly lower inhibition zone (12.0 ± 0.09 to 13.0 
± 0.09 mm) than propolis against S. aureus in disc 
diffusion method (Figure 2). On the contrary higher 
inhibition zone (10.0 mm) was recorded from propolis at 
the concentration of 5.48 mg ml-1 followed by lower to 
lowest concentrations against E. coli (Figure 1). On the 
contrary honey showed slightly lower inhibition zone (7.0 
to 7.5 mm) than propolis against E. coli in disc diffusion 
method (Figure 2). The minimum inhibitory concentration 
of propolis and honey against S. aureus and E. coli are 
presented in Tables 1 and 2. Growth and no growth tubes 
were identified comparing to the turbidity of the positive 
control. The negative growth was observed in propolis at 
concentrations of 2.74 to 5.48 mgml-1 while growth was 
observed at concentrations of 1.37 mgml-1 followed by 
lower concentrations. The negative growth was observed 
in honey only at the highest concentration up to 375.0 mg  
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Figure 2. Zone of inhibition by application of honey against E. coli and S. aureus by disc diffusion method.  
 
 
 
Table 1. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of propolis and honey 
against S. aureus. 
  
Concentration (mg/ml) Propolis Honey Dilution 
Propolis Honey MIC MBC MIC MBC 
1/2 5.48 375.0 - - - - 
1/4 2.74 187.5 - - + + 
1/8 1.37 93.75 + + + + 
1/16 0.68 46.88 + + + + 
1/32 0.34 23.44 + + + + 
1/64 0.17 11.72 + + + + 
1/128 0.085 5.86 + + + + 
1/256 0.043 2.93 + + + + 
 
(-) represents inhibition; (+) represents growth 
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Table 2. Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC) of propolis and honey 
against E. coli. 
  
Concentration (mg/ml) Propolis Honey Dilution 
Propolis Honey MIC MBC MIC MBC 
1/2 5.48 375.0 - - + + 
1/4 2.74 187.5 + + + + 
1/8 1.37 93.75 + + + + 
1/16 0.68 46.88 + + + + 
1/32 0.34 23.44 + + + + 
1/64 0.17 11.72 + + + + 
1/128 0.085 5.86 + + + + 
1/256 0.043 2.93 + + + + 
 
(-) represents inhibition; (+) represents growth 
 
 
 
Table 3. Inhibitory concentration of propolis and honey against S. aureus and E. coli under gradient-plate technique. 
 
Inhibited line length (cm) Inhibitory concentration (mg ml-1) Test organism Growth line length (cm) 
Propolis Honey Propolis Honey 
S. aureus 7.50 ± 0.0 2.38 ± 0.66 3.50 ± 2.00 3.50 ± 0.96 350.0 ±  200 
E. coli 7.50 ±  0.0 3.70 ± 0.66 7.50 ± 2.00 5.41 ± 0.96 750.0 ± 200 
 
 
 
ml-1 while growth was observed at lower concentrations 
against S. aureus (Table 1). In case of E. coli, negative 
growth was observed in propolis at the concentration of 
only 5.48 mgml-1 while growth was observed at lower 
con-entrations. Regardless of concentration honey failed 
to show any effectiveness against growth of E. coli (Table 
2). 
The MBC of propolis and honey against S. aureus and 
E. coli grown in TSA plate are presented in Table 2. TSA 
plates (spot plate) streaked from no growth (negative 
growth) tubes showed no colonies while streaked from 
positive tubes showed colonies of Staphylococcus aureus 
and E. coli. The result of MBC value of the propolis and 
honey against S. aureus and E. coli was exactly similar 
compared to MIC value. Gradient plate technique showed 
both growth and inhibition of growth on streaked line. 
Total line length in gradient plate was 7.5 cm and inhi-
bited growth line from propolis and honey showed 2.38 
and 3.50 cm at concentrations of 3.5 and 350 mgml-1, 
respectively against S. aureus (Table 3). The inhibited 
growth line from propolis and honey showed 3.7 and 7.50 
cm at concentrations of 5.41 and 750 mgml-1, 
respectively against E. coli (Table 3). This concentration 
is relatively closer with MIC and MBC concentration of 
propolis and honey against S. aureus and E. coli.  
 
 
DISCUSSION 
 
Both propolis and honey evaluated in  this  study  showed 
antibacterial activity against S. aureus in disc diffusion 
method, MIC, MBC and gradient plate technique. 
Significant response was noticed in disk diffusion assay 
in propolis and honey against S. aureus but propolis at 
higher concentration was only effective to inhibit E. coli. 
The MIC results from propolis of the present study 
observed that 2.74 mgml-1 is effective against S. aureus. 
Similar MIC results from propolis (2.01 to 3·65 mgml-1) 
was obtained by Miorin et al. (2003). Bonvehiet et al., 
(1994) investigated propolis from A. mellifera against S. 
aureus where MIC values ranged from 0.080 to 
0.100 mgml-1. These MIC results are different than the 
MICs found to be active in this study because of different 
methodologies to determine antibacterial activity. Propolis 
against S. aureus was studied by agar dilution method 
and found average MIC was 22.5 mgml-1 (Fernandez et 
al., 1995). Propolis samples had higher antibacterial 
activity against S. aureus when compared with honey 
samples.  
Similar results were reported by (Miorin et al., 2003). 
Present study showed that propolis inhibited the gram-
positive bacteria better than gram-negative bacteria. 
Generally, plant extracts are usually more active against 
gram-positive bacteria than gram-negative bacteria (Lin 
et al., 1999). Present findings were also supported by 
other researchers who reported that the crude powder of 
the galls of Quercus infectoria was found to be active 
against S. aureus (Fatima et al., 2001). The range of MIC 
values for S. aureus and E. coli correlated well with the 
results  obtained  using  the  gradient plate technique and  
  
 
 
 
correlates with disc diffusion method. Both honey and 
propolis contain some phenolic substances which include 
cinnamic acid derivatives and some flavonoids (Marcucci 
et al., 2001). The main compounds available in propolis 
are acids such as caffeic, p-Coumaric acid, 3-prenyl-4-
hydroxycinnamic, 3,5-diprenyl-4-hydroxycinnamic, 2,2-
dimethyl-8-prenyl-2H-1-benzopyran-6-propenoic, a 
kaempferol derivative (flavonoid) and 2,2-dimethyl-6-
carboxyethenyl-2H-1-benzopyran (Marcucci and 
Bankova, 1999; Bankova et al., 2000; Marcucci et al., 
2001). In addition comparartively higher 4-
Hydroxybenzoic acid is present in propolis than honey. 
This may be due to the fact that for asepsis bees cover 
the comb with a thin layer of propolis before the honey is 
deposited. The antibacterial activity of propolis may be 
related to the presence of flavonoids (Bosio et al., 2000). 
Takaisi-Kikuni and Schilcher (1994) and Nieva Moreno et 
al. (1999) have shown that propolis extracts have 
antibacterial properties against some micro-organisms. 
Antibacterial activity of propolis against S. aureus was 
ovserved mainly because of the presence of most active 
compounds such as triterpenic acids where communic 
and imbricatoloic acids and isocupressic methyl ester 
(Bankova et al., 1996). Kaurenoic acid which is a newly 
identified compound showed higher inhibitory activity 
than streptomycin against S. aureus (Velikova et al., 
2000a). Miorin et al. (2003) suggested that effectiveness 
of honey or propolis depends on differences in chemical 
composition, bee species and geographic region.  
The MIC and MBC methods are simple and easy for the 
determination of inhibitory doses of antibiotics or 
disinfectant for particular bacteria. The effectiveness of 
antibiotic properties of propolis found that propolis was 
equal to or slightly more effective than two common 
antibiotics, erythromycin and amoxicillin, in killing S. 
aureus and Streptococcus faecalis bacteria (Zumla and 
Lulat, 1989). Honey inhibits the growth of dangerous 
bacteria such as E. coli, S. aureus, Salmonella, Shigella, 
and V. cholera (Zumla and Lulat, 1989). The 
concentration of honey varied 30 to 50% was bactericidal 
to S. shigella, E. coli and v. cholera, making honey an 
anti-bacterial agent and superior to several well-known 
and currently prescribed antibiotics. Honey inhibits the 
growth of pathogenic organisms isolated in urine samples 
of patients with urinary tract infections as well (Somal et 
al., 1994).  
 
Nieva Morneo et al. (1999) reported that ethanolic 
extracts of propolis showed high antibacterial activity 
against gram-positive cocci (S. aureus), but had a weak 
activity against gram-negative bacteria (E. coli and 
Pseudomonas aeruginosa) and yeast (Candida albicans). 
Propolis is active against Gram-positive bacteria, 
showing limited activity against Gram-negative ones 
(Grange and Davey, 1990). From the above results it 
appears   that  E. coli  is  more   resistant  than  S. aureus  
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against propolis and honey. E. coli is considered a 
particularly dangerous pathogen because of its 
resistance to many commonly used antibiotics.  
Therefore, to prevent contamination from E. coli higher 
concentrated propolis or more effective disinfectant/ 
antibiotic should be applied. E. coli is a gram negative 
bacteria and it is notorious for its resistance to many 
antibiotics due to the permeability barrier afforded by its 
outer membrane (Viveiros et al., 2007). 
 
 
Conclusion 
 
Disc diffusion method is a very useful tools to evaluate 
effectiveness of natural antibiotics. Gradient-plate 
technique is also used as a counterpart method of MIC 
and MBC. Both MIC and MBC methods are simple and 
easy for the determination of inhibitory doses of propolis 
and honey for S. aureus. Propolis and honey 
concentrations at rates of 2.74 - 5.48 and 375.0 mgml-1 
can be applied to inhibit S. aureus.  
Collectively, present findings revealed that propolis had 
higher antibacterial activity against S. aureus when 
compared with honey and more susceptible than E. coli. 
Antimicrobial properties would warrant further studies on 
the clinical applications of propolis and honey against S. 
aureus. Higher concentration of propolis and honey singly 
or combined application of both to be further investigated 
to inhibit E. coli. 
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